digestive disorder
Conditions
Interventions
Number of subjects : 12 Period of study: 2 days 1) Volunteers are fasted overnight. 2) Volunteers are administered three kinds of drugs (Pitavastatin calcium, Glimepiride, Lansoprazole) orally a
Sponsors
Faculty of Pharmaceutical Sciences, Setsunan University
Towa Pharmaceutical Co. Ltd.
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1) Men, Japanese, If students, this volunteer shop does not affect the required course in their University. 2) BMI is 18.5>= and <25.0.
Exclusion criteria
Exclusion criteria: 1)Who having (or had) a medical history of circulatory system disease, hepatic disease, renal disease, digestive system disease, hematological disorder. 2)Who taking a medicine that night affect the study result. 3)Who judged as inappropriate to this study by the primary doctor of this study from diagnosis, vital signs, inductive electrocardiograph, hematological assessment, blood biochemical test, urinary test, immunological test. 4)Who took a medicine within 7 days before the study 5)Who participated in the clinical trail and took a test medicine within 3 months before the study. 6)Who having (or had) an allergic constitution to medicine/food 7)Who having (or had) a dependency to drug or alcohol 8)Who judged as inappropriate to this study by the primary doctor due to any other reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood concentration profile of each drug after oral administration with or without water ingestion. | — |
Countries
Japan
Contacts
Public ContactShinji Yamashita
Setsunan University Faculty of Pharmaceutical Sciences
Outcome results
None listed